Pepdox
Studies
Peptides
Calculator
Generalizability of SURPASS-CVOT to the United States: A Nationally Representative Study. | Pepdox
Home
/
Search
/
PMID 40907677
Generalizability of SURPASS-CVOT to the United States: A Nationally Representative Study.
Progress in cardiovascular diseases
2025
PMID: 40907677
View on PubMed
DOI: 10.1016/j.pcad.2025.08.009
Tirzepatide
Authors
Aggarwal, Rahul; Nicholls, Stephen J; D'Alessio, David; Bhatt, Deepak L
Keywords
Cardiovascular outcomes trial
Cardiovascular-kidneymetabolic syndrome
Generalizability
Real-world evidence
Tirzepatide